• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在表达BCR-Abl的细胞系以及白血病患者来源的外周血细胞中JAKs和STATs的组成性激活。

Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.

作者信息

Chai S K, Nichols G L, Rothman P

机构信息

Department of Medicine, College of Physicians and Surgeons, Columbia University, New York 10032, USA.

出版信息

J Immunol. 1997 Nov 15;159(10):4720-8.

PMID:9366395
Abstract

An important step in the oncogenic transformation of hemopoietic cells and the subsequent development of leukemia is the proliferation of tumor cells in the absence of exogenous growth factors. In most cases of chronic myelocytic leukemia and in some cases of acute myelocytic leukemia and acute lymphocytic leukemia, the bcr-abl oncogene is involved in this process. Although the BCR-Abl oncoprotein demonstrates enhanced tyrosine kinase activity in leukemic cells, the mechanism by which this leads to growth factor independence remains poorly defined. One proposed mechanism is the activation of cytokine signal transduction pathways, possibly by an autocrine loop involving IL-3 and/or granulocyte-macrophage CSF. Examination of several different cell lines expressing BCR-Abl demonstrates that some of these cells have constitutive activation of the JAK/STAT signaling pathway. We have found the constitutive activation of STAT5 in most, but not all, cell lines expressing BCR-Abl. This constitutive activation of STAT5 is variably associated with a corresponding activation of JAK kinases. Ab blocking studies show that the activation of STAT5 in these cell lines cannot be attributed to the activation of an IL-3/granulocyte-macrophage CSF-driven autocrine loop. Interestingly, samples of peripheral blood cells derived from patients with acute myelocytic leukemia and chronic myelocytic leukemia, which express BCR-Abl, demonstrate constitutive activation of STAT family members. These studies suggest that in a variety of leukemic states, BCR-Abl may use a bypass mechanism to activate cytokine signal transduction pathways.

摘要

造血细胞致癌转化及随后白血病发展过程中的一个重要步骤是肿瘤细胞在无外源性生长因子情况下的增殖。在大多数慢性粒细胞白血病病例以及一些急性粒细胞白血病和急性淋巴细胞白血病病例中,bcr-abl癌基因参与了这一过程。尽管BCR-Abl癌蛋白在白血病细胞中显示出增强的酪氨酸激酶活性,但导致其不依赖生长因子的机制仍不清楚。一种提出的机制是细胞因子信号转导途径的激活,可能是通过涉及IL-3和/或粒细胞-巨噬细胞集落刺激因子的自分泌环。对几种表达BCR-Abl的不同细胞系的研究表明,其中一些细胞具有JAK/STAT信号通路的组成性激活。我们发现在大多数(但不是全部)表达BCR-Abl的细胞系中STAT5有组成性激活。STAT5的这种组成性激活与JAK激酶的相应激活存在不同程度的关联。抗体阻断研究表明,这些细胞系中STAT5的激活不能归因于IL-3/粒细胞-巨噬细胞集落刺激因子驱动的自分泌环的激活。有趣的是,来自表达BCR-Abl 的急性粒细胞白血病和慢性粒细胞白血病患者的外周血细胞样本显示出STAT家族成员的组成性激活。这些研究表明,在多种白血病状态下,BCR-Abl可能利用一种旁路机制来激活细胞因子信号转导途径。

相似文献

1
Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.在表达BCR-Abl的细胞系以及白血病患者来源的外周血细胞中JAKs和STATs的组成性激活。
J Immunol. 1997 Nov 15;159(10):4720-8.
2
Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.选择性吡咯并嘧啶抑制剂揭示了Src家族激酶在Bcr-Abl信号转导和肿瘤发生中的必要作用。
Oncogene. 2002 Nov 21;21(53):8075-88. doi: 10.1038/sj.onc.1206008.
3
Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells.PD180970对Bcr-Abl激酶活性的抑制作用可阻断Stat5的组成性激活及慢性粒细胞白血病细胞的生长。
Oncogene. 2002 Dec 12;21(57):8804-16. doi: 10.1038/sj.onc.1206028.
4
Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.在被Bcr/Abl转化的造血细胞系中,信号转导子和转录激活子(STAT)蛋白的酪氨酰磷酸化及DNA结合活性
J Exp Med. 1996 Mar 1;183(3):811-20. doi: 10.1084/jem.183.3.811.
5
Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts.急性髓系白血病原始细胞中转录信号转导子和激活子蛋白的表达
Cancer Res. 1998 Jul 15;58(14):3173-80.
6
Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines.JAK2/STAT5信号转导通路的组成性激活与巨核细胞白血病细胞系的生长因子非依赖性相关。
Blood. 1999 Apr 1;93(7):2369-79.
7
Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.慢性髓性白血病患者中BCL-X(L)表达及STAT5磷酸化的差异
Eur J Haematol. 2004 Apr;72(4):231-8. doi: 10.1046/j.0902-4441.2003.00201.x.
8
Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia.在慢性粒细胞白血病中,BCR-ABL致癌基因对信号转导和转录激活因子5(STAT5)的组成性激活。
Oncogene. 1996 Jul 18;13(2):247-54.
9
Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line.白细胞介素-3和p210 BCR/ABL在一种因子依赖性髓系细胞系中激活信号转导的独特和重叠途径。
Exp Hematol. 1993 Oct;21(11):1460-6.
10
Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells.BCR-ABL在胚胎干细胞中对STAT3的组成性及特异性激活作用
Oncogene. 2003 Jun 26;22(26):4102-10. doi: 10.1038/sj.onc.1206607.

引用本文的文献

1
Autophagy and Cancer: Insights into Molecular Mechanisms and Therapeutic Approaches for Chronic Myeloid Leukemia.自噬与癌症:慢性髓性白血病分子机制及治疗方法的见解
Biomolecules. 2025 Feb 2;15(2):215. doi: 10.3390/biom15020215.
2
BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia.BCR-ABL1酪氨酸激酶复合物信号转导:克服慢性髓性白血病耐药性面临的挑战
Pharmaceutics. 2022 Jan 17;14(1):215. doi: 10.3390/pharmaceutics14010215.
3
Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells.
揭示靶向慢性粒细胞白血病干细胞的奥秘
J Clin Med. 2021 Dec 11;10(24):5805. doi: 10.3390/jcm10245805.
4
Chronic myeloid leukemia stem cells: targeting therapeutic implications.慢性髓性白血病干细胞:靶向治疗的意义。
Stem Cell Res Ther. 2021 Dec 18;12(1):603. doi: 10.1186/s13287-021-02659-1.
5
Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia.靶向 Ph+ 急性淋巴细胞白血病的 CDK6 依赖性。
Genes (Basel). 2021 Aug 29;12(9):1355. doi: 10.3390/genes12091355.
6
Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation.慢性髓性白血病联合疗法实现潜在无治疗缓解:聚焦白血病干细胞与免疫调节
Front Oncol. 2021 May 13;11:643382. doi: 10.3389/fonc.2021.643382. eCollection 2021.
7
The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation.酪氨酸激酶c-Abl通过STAT1磷酸化增强干扰素介导的抗病毒免疫。
iScience. 2021 Jan 21;24(2):102078. doi: 10.1016/j.isci.2021.102078. eCollection 2021 Feb 19.
8
Persistent STAT5 activation reprograms the epigenetic landscape in CD4 T cells to drive polyfunctionality and antitumor immunity.持续的 STAT5 激活重新编程 CD4 T 细胞中的表观遗传景观,以驱动多功能性和抗肿瘤免疫。
Sci Immunol. 2020 Oct 30;5(52). doi: 10.1126/sciimmunol.aba5962.
9
DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cells.DYRK2 控制慢性髓性白血病干细胞中的关键调控网络。
Exp Mol Med. 2020 Oct;52(10):1663-1672. doi: 10.1038/s12276-020-00515-5. Epub 2020 Oct 16.
10
Metabolic underpinnings of leukemia pathology and treatment.白血病病理和治疗的代谢基础。
Cancer Rep (Hoboken). 2019 Apr;2(2):e1139. doi: 10.1002/cnr2.1139. Epub 2018 Oct 7.